Drug Index
MYCOSTATIN
Generic: NYSTATIN
Marketing status: Discontinued
- Route: TOPICAL
- Class: Cardiovascular
- Safety profile: generic
- Latest regulatory update: 02 Apr 2026, 09:13 pm (UTC)
Structured Monograph
Approval overview MYCOSTATIN is listed in Drugs@FDA under application 060571 (ANDA). Marketing status: Discontinued Active ingredient NYSTATIN Form and strength OINTMENT;TOPICAL - 100,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor DELCOR ASSET CORP Submission history See approval history documents.